These authors contributed equally: Anna K. Casasent, Mathilde M. Almekinders, Charlotta Mulder.
Department of Genetics, MD Anderson Cancer Center, Houston, TX, USA
Anna K. Casasent, Nicholas E. Navin, Andrew Futreal & Nicholas E. Navin
Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands
Mathilde M. Almekinders, Charlotta Mulder, Proteeti Bhattacharjee, Jos Jonkers, Esther H. Lips, Jacco van Rheenen, Jelle Wesseling, Jacco van Rheenen & Marjanka Schmidt
Patient Advocates in Research, Danville, CA, USA
Deborah Collyar
Division of Surgical Oncology, Baylor College of Medicine, Houston, TX, USA
Alastair M. Thompson
Duke University Hospital, Duke University, Durham, NC, USA
E. Shelley Hwang & E. Shelley Hwang
Department of Medical Genetics, University of Cambridge, Cambridge, UK
Serena Nik-Zainal & Helen R. Davies
Department of Bioinformatics, MD Anderson Cancer Center, Houston, TX, USA
Nicholas E. Navin, Andrew Futreal & Nicholas E. Navin
Department of Pathology, Leiden University Medical Center, Leiden, Netherlands
Jelle Wesseling
Guy’s Cancer Centre, King’s College London, London, UK
Elinor J. Sawyer
Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas, USA
Fariba Behbod
Computational Cancer Biology, Netherlands Cancer Institute, Amsterdam, Netherlands
Lodewyk F. A. Wessels
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
Daniel Rea
Independent Cancer Patients’ Voice, London, UK
Hilary Stobart
DCIS 411, San Diego, CA, USA
Donna Pinto
Dutch Breast Cancer Society (Borstkankervereniging Nederland), Utrecht, Netherlands
Ellen Verschuur & Marja van Oirsouw
留言 (0)